Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CTSL | P07711 | 2/20 | 0.47 |
| ▸ | FKBP1A | P62942 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7343776 | 0.99 | ALDH1A1 (0.52) | ALDH1A1MEN1KMT2ALMNACTSL | |
| SCHEMBL27306803 | 0.88 | ALDH1A1 (0.49) | ALDH1A1MEN1KMT2ALMNANPC1 | |
| SCHEMBL7350833 | 0.88 | IDO1 (0.49) | ALDH1A1NPC1RAB9ASMN1; SMN2SIGMAR1 | |
| SCHEMBL7349999 | 0.86 | MEN1 (0.56) | ALDH1A1MEN1KMT2ALMNAFKBP1A | |
| SCHEMBL9224504 | 0.85 | ALDH1A1 (0.46) | ALDH1A1MEN1KMT2ALMNACTSL | |
| SCHEMBL8120754 | 0.83 | FKBP1A (0.43) | ALDH1A1MEN1KMT2ALMNACTSL | |
| SCHEMBL8475131 | 0.83 | FKBP1A (0.43) | ALDH1A1MEN1KMT2ALMNACTSL | |
| SCHEMBL10642077 | 0.82 | SLC6A2 (0.49) | ALDH1A1MEN1KMT2ALMNANPC1 | |
| SCHEMBL24534624 | 0.81 | ALDH1A1 (0.49) | ALDH1A1MEN1KMT2ALMNACTSL | |
| SCHEMBL25948326 | 0.81 | ALDH1A1 (0.49) | ALDH1A1MEN1KMT2ALMNACTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5436240-A | Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines | THE UPJOHN COMPANY (US) | 1995-07-25 | — | — | US | disclosed |
| EP-0480939-B1 | HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY | UPJOHN CO (US) | 1995-01-25 | — | — | EP | disclosed |
| US-5273975-A | Heterocyclic amines having central nervous system activity | THE UPJOHN COMPANY (US) | 1993-12-28 | — | — | US | disclosed |
| EP-0480939-A1 | HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. | UPJOHN CO (US) | 1992-04-22 | — | — | EP | disclosed |
| WO-1990015058-A1 | HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY | THE UPJOHN COMPANY (US) | 1990-12-13 | — | — | WO | disclosed |